CRISPR and Blood Diseases

Michael discusses the groundbreaking use of CRISPR to treat sickle cell disease, highlighting the success story of Victoria, who experienced a remarkable improvement in her quality of life. The conversation delves into why blood diseases are particularly amenable to CRISPR treatment, emphasizing factors like accessibility and rapid cell turnover. However, ethical concerns arise when considering genetic changes to embryos, where the individual has no say in the matter.